Julie Parsonnet

Professor

Stanford University

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Julie Parsonnet is a Professor at Stanford University, located in the United States. Her research focuses on infectious diseases, particularly in relation to malaria chemoprevention and COVID-19 response metrics. Recent works include studies on the use of wastewater metrics to monitor COVID-19 spread, as well as evaluating treatment methods for patients with COVID-19.

Articles (15)

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (3)

Jason Andrews

Associate Professor

Stanford University School of Medicine

UNITED STATES

View details

Maria Montez-Rath

Stanford University School of Medicine

UNITED STATES

View details

Guodong Zhang

University of California, Davis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Julie Parsonnet

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Monthly Sulfadoxine-Pyrimethamine During Pregnancy Prevents Febrile Respiratory Illnesses: A Secondary Analysis of a Malaria Chemoprevention Trial in Uganda

Feasibility and Acceptability of SARS-CoV-2 Screening among Patients Receiving Hemodialysis

Microbiota-mediated reactivation of triclosan oxidative metabolites in colon tissues

Use of Wastewater Metrics to Track COVID-19 in the US

Evaluation of Acebilustat, a Selective Inhibitor of Leukotriene B4 Biosynthesis, for Treatment of Outpatients With Mild-Moderate Coronavirus Disease 2019 (COVID-19): A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Use of wastewater metrics to track COVID-19 in the U.S.: a national time-series analysis over the first three quarters of 2022

Microbial enzymes induce colitis by reactivating triclosan in the mouse gastrointestinal tract

SARS-CoV-2 Infection during the Omicron Surge among Patients Receiving Dialysis: The Role of Circulating Receptor-Binding Domain Antibodies and Vaccine Doses

Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2

Validity of at-home rapid antigen lateral flow assay and artificial intelligence read to detect SARS-CoV-2

Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study

Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study

TNF-a(+) CD4(+) T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodies

Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection

SARS-CoV-2 Booster Vaccine Response among Patients Receiving Dialysis

Collaborators (3)

Jason Andrews

Maria Montez-Rath

Guodong Zhang

Make your next move.